The DOI matches its Crossref record; 23 of the 24 references it cites were found in a registry or an index; 1 of the 18 sources its claims cite were checked for support.
Evaluation of the Endorsement of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Statement on the Quality of Published Systematic Review and Meta-Analyses
Open accessAbstract
INTRODUCTION: PRISMA statement was published in 2009 in order to set standards in the reporting of systematic reviews and meta-analyses. Our aim was to evaluate the impact of PRISMA endorsement on the quality of reporting and methodological quality of systematic reviews and meta-analyses, published in journals in the field of gastroenterology and hepatology (GH). METHODS: Quality of reporting and methodological quality were evaluated by assessing the adherence of papers to PRISMA checklist and AMSTAR quality scale. After identifying the GH journals which endorsed PRISMA in instructions for authors (IA), we appraised: 15 papers published in 2012 explicitly mentioning PRISMA in the full text (Group A); 15 papers from the same journals published in 2012 not explicitly mentioning PRISMA in the full text (Group B); 30 papers published the year preceding PRISMA endorsement from the same journals as above (Group C); 30 papers published in 2012 on the 10 highest impact factor journals in GH which not endorsed PRISMA (Group D). RESULTS: PRISMA statement was referred in the IA in 9 out of 70 GH journals (12.9%). We found significant increase in overall adherence to PRISMA checklist (Group A, 90.1%; Group C, 83.1%; p = 0.003) and compliance to AMSTAR scale (Group A, 85.0%; Group C, 74.6%; p = 0.002), following the PRISMA endorsement from the nine GH journals. Explicit referencing of PRISMA in manuscript was not associated with increase in quality of reporting and methodological quality (Group A vs. B, p = 0.651, p = 0.900, respectively). Adherence to PRISMA checklist, and the compliance with AMSTAR were significantly higher in journals endorsing PRISMA compared to those not (Groups A+B vs. D; p = 0.003 and p = 0.016, respectively). CONCLUSION: The endorsement of PRISMA resulted in increase of both quality of reporting and methodological quality. It is advised that an increasing number of medical journals include PRISMA in the instructions for authors.
Overview
CoChat Summary
TL;DR
In gastroenterology and hepatology journals, PRISMA endorsement in instructions for authors was associated with higher reporting and methodological quality of systematic reviews/meta-analyses. Explicitly mentioning PRISMA in the manuscript was not associated with better quality.
Key findings
- PRISMA was referenced in the instructions for authors by 9 of 70 gastroenterology and hepatology journals (12.9%).
- After PRISMA endorsement, overall adherence to the PRISMA checklist increased from 83.1% (Group C, pre-endorsement) to 90.1% (Group A, post-endorsement; p = 0.003), and AMSTAR compliance increased from 74.6% to 85.0% (p = 0.002).
- Explicit PRISMA mention in the full text was not associated with higher quality: Group A vs. Group B p = 0.651 for PRISMA adherence and p = 0.900 for AMSTAR compliance.
- Journals endorsing PRISMA had significantly higher adherence/compliance than non-endorsing top GH journals (Groups A+B vs. Group D: p = 0.003 for PRISMA and p = 0.016 for AMSTAR).
Methods
- Evaluated 90 systematic reviews/meta-analyses from GH journals: Group A (n = 15) explicitly mentioned PRISMA in 2012 from 9 endorsing journals; Group B (n = 15) from the same journals did not explicitly mention PRISMA; Group C (n = 30) was published in the same journals the year preceding PRISMA endorsement; Group D (n = 30) came from the top 10 GH journals that never endorsed PRISMA.
- Quality of reporting was assessed with the 27-item PRISMA checklist; methodological quality was assessed with the AMSTAR scale, modified by excluding items 5 and 11. Two researchers scored independently, with a third consulted for disagreements.
- Comparisons used chi-square or Fisher tests; continuous variables were described as medians and interquartile ranges and compared with the nonparametric Wilcoxon rank-sum test using Stata.
Limitations
- Stated: the study was restricted to systematic reviews and meta-analyses published in GH journals; the authors could not retrieve information on potential former QUORUM adoption from the nine PRISMA-endorsing journals, so QUORUM rather than PRISMA could have affected quality, though they argue against this.
- Evident: the observational before/after and cross-sectional design cannot establish causation; several groups were small (n = 15 for Groups A and B); AMSTAR was modified; and only 9 endorsing journals in one field and time frame limit generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
1 Valid · 0 Not valid · 12 Not checked · 28 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Adherence to PRISMA checklist, and the compliance with AMSTAR were significantly higher in journals endorsing PRISMA compared to those not (Groups A+B vs. D; p = 0.003 and p = 0.016, respectively).”
- Also stated in: § Critical appraisal of systematic reviews and meta-analyses published in GH journals · plain
“Significant difference was observed in the overall adherence to PRISMA (p = 0.003) and compliance with AMSTAR (p = 0.016) (Tables 1 and 2).”
§ Evaluation of the Endorsement of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Statement on the Quality of Published Systematic Review and Meta-Analyses > Abstract > Results
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Critical appraisal of systematic reviews and meta-analyses published in GH journals · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“PRISMA statement was referred in the IA in 9 out of 70 GH journals (12.9%).”
- Also stated in: § Assessing endorsement · plain
“the PRISMA Statement was referred in the instructions for authors in 9 journals (12.9%; namely: Alimentary Pharmacology & Therapeutics, American Journal of Gastroenterology, BMC Gastroenterology, Colorectal Disease, Diseases Of The Colon & Rectum, Gut, Gut Pathogens, Hepatitis Monthly and HPB).”
§ Evaluation of the Endorsement of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Statement on the Quality of Published Systematic Review and Meta-Analyses > Abstract > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Assessing endorsement · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“as well as to any particular PRISMA or AMSTAR item (Tables 1 and 2).”
§ Evaluation of the Endorsement of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Statement on the Quality of Published Systematic Review and Meta-Analyses > Results > Critical appraisal of systematic reviews and meta-analyses published in GH journals
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean IF of the 90 papers was significantly higher in group C compared to group A (p = 0.023)”
§ Evaluation of the Endorsement of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Statement on the Quality of Published Systematic Review and Meta-Analyses > Results > Critical appraisal of systematic reviews and meta-analyses published in GH journals
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Explicit referencing of PRISMA in manuscript was not associated with increase in quality of reporting and methodological quality (Group A vs. B, p = 0.651, p = 0.900, respectively).”
- Also stated in: § Critical appraisal of systematic reviews and meta-analyses published in GH journals · plain
“Results show that there was no difference in both the overall adherence to PRISMA and compliance with AMSTAR”
§ Evaluation of the Endorsement of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Statement on the Quality of Published Systematic Review and Meta-Analyses > Abstract > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Critical appraisal of systematic reviews and meta-analyses published in GH journals · plain
14 more claims
Create a free account to see all 41 claims and to verify the 17 references still open.
- Probably not a substantial claim. 15
- It may state two separate claims as one. 11
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Evidence from observational studies suggests that use of the PRISMA 2009 statement is associated with more complete reporting of systematic reviews [17-20] , although more could be done to improve adherence to the guideline [21] .”
From The PRISMA 2020 statement: An updated guideline for reporting systematic reviews (2021) · cites this paper as [18]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Various strategies to increase the use of reporting guidelines and improve reporting have been proposed.”
From The PRISMA 2020 statement: An updated guideline for reporting systematic reviews (2021) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“Evidence from observational studies suggests that use of the PRISMA 2009 statement is associated with more complete reporting of systematic reviews,[17–20] although more could be done to improve adherence to the guideline.[21]”
From The PRISMA 2020 statement: An updated guideline for reporting systematic reviews (2021) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“La evidencia proveniente de estudios observacionales sugiere que el uso de la declaracio ´ n PRISMA 2009 esta ´ asociada a publicaciones ma ´ s completas de revisiones sistema ´ticas 16-19 aunque se podrı ´a hacer ma ´ s para mejorar la adhesio ´ n a la guı ´a 20 .”
From Declaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas (2021) · cites this paper as [17]
The cited source says what the claim attributes to it.
In the citing paper
“Se han propuesto varias estrategias para aumentar el uso de las guı ´as de presentacio ´ n de publicaciones y mejorar su presentacio ´ n.”
From Declaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas (2021) · cites this paper as [17]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Evaluation of the Endorsement of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Statement on the Quality of Published Systematic Review and Meta-Analyses > Introduction
“That led to development of the QUality Of Reporting Of Meta-analysis (QUOROM) statement in 1996 [6]”
§ Evaluation of the Endorsement of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Statement on the Quality of Published Systematic Review and Meta-Analyses > References
“6. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, et al (1994) Improving the quality of reporting of meta-analysis of randomized controlled trials: The QUOROM statement.”
Citations
Cites
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00136 · Cited by 10,349
Vandenbroucke, J. P., von Elm, E., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., Egger, M., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040297 · Cited by 8,613 · cited 1×
“On the other hand, after endorsement of Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement [15], the quality of reporting of published observational studies was still reported as unsatisfactory [16].”
BackgroundMoher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826
Development of AMSTAR: A measurement tool to assess the methodological quality of systematic reviews
Shea, B. J., Grimshaw, J. M., Wells, G. A., Boers, M., Andersson, N., Hamel, C., Porter, A. C., Tugwell, P., Moher, D., & Bouter, L. M. (2007) · BMC Medical Research Methodology · doi:10.1186/1471-2288-7-10 · Cited by 4,374
Vandenbroucke, J. P., Elm, E. V., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., Egger, M., & initiative, F. T. S. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00010-w1 · Cited by 3,543
Shea, B. J., Hamel, C., Wells, G. A., Bouter, L. M., Kristjansson, E., Grimshaw, J., Henry, D. A., & Boers, M. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2008.10.009 · Cited by 1,755
Epidemiology and reporting characteristics of systematic reviews.
Moher, D., Tetzlaff, J., Tricco, A. C., Sampson, M., & Altman, D. G. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040078 · Cited by 891
The Medical Review Article: State of the Science
MULROW, C. D. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-3-485 · Cited by 856
An international registry of systematic-review protocols
Booth, A., Clarke, M., Ghersi, D., Moher, D., Petticrew, M., & Stewart, L. (2011) · The Lancet · doi:10.1016/s0140-6736(10)60903-8 · Cited by 512
Cited by
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · Systematic Reviews · doi:10.1186/s13643-021-01626-4 · Cited by 13,874
The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · International Journal of Surgery · doi:10.1016/j.ijsu.2021.105906 · Cited by 11,748
Hutton, B., Salanti, G., Caldwell, D. M., Chaimani, A., Schmid, C. H., Cameron, C., Ioannidis, J. P. A., Straus, S., Thorlund, K., Jansen, J. P., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2385 · Cited by 8,269
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003583 · Cited by 5,148
“They include educators introducing reporting guidelines into graduate curricula to promote good reporting habits of early career scientists [65]; journal editors and regulators endorsing use of reporting guidelines [18]; peer reviewers evaluating adherence to reporting guidelines [61, 66]; journals requiring authors t…”
Background
Metadata
- Authors
- Panic, N., Leoncini, E., de Belvis, G., Ricciardi, W., & Boccia, S.
- Affiliations
- Università Cattolica del Sacro Cuore (IT)
- Corresponding author
- Boccia, Stefania
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-12-26
- Volume
- 8
- Issue
- 12
- Pages
- e83138
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3873291
- OpenAlex
- W2093152548
- Semantic Scholar
- df75cf48dc55fbc99073132e892e39d34a1e1731
- Cited by
- 883
- References
- 24
- Citations by year
- 2026: 44 · 2025: 57 · 2024: 105 · 2023: 72 · 2022: 69 · 2021: 99 · 2020: 87 · 2019: 83 · 2018: 67 · 2017: 78 · 2016: 73 · 2015: 32 · 2014: 17
- FWCI
- 8.33
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- PubliCatt (Università Cattolica del Sacro Cuore) (submittedVersion, other-oa)
- Topics
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Social Sciences › Library and Information Sciences › Academic Publishing and Open Access
- Keywords
- PRISMA statement, reporting quality, systematic reviews, meta-analysis, methodological quality, AMSTAR, author guidelines, gastroenterology journals
- MeSH terms
- Systematic Reviews as Topic, Gastroenterology, Periodicals as Topic, Publishing, Quality Control, Meta-Analysis as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evaluation of the Endorsement of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Statement on the Quality of Published Systematic Review and Meta-Analyses. https://app.cochat.ai/papers/10.1371/journal.pone.0083138
- The paper
- Panic, N., Leoncini, E., de Belvis, G., Ricciardi, W., & Boccia, S. (2013). Evaluation of the Endorsement of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Statement on the Quality of Published Systematic Review and Meta-Analyses. PLoS ONE. https://doi.org/10.1371/journal.pone.0083138
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.